HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Cefoperazone in the treatment of infections of the gallbladder, biliary ducts and liver in surgical patients].

Abstract
In 20 patients treated on account of advanced cholecystitis, inflammations of the biliary pathways and liver a cephalosporin of the third generation, cefoperazone, was administered within the framework of antimicrobial treatment after surgery or after endoscopic intervention. In the laboratory investigation of the study in isolated bacteria minimal inhibitory concentrations and serum, biliary and tissue levels of cefoperazone were assessed. The minimal inhibitory concentrations in the assessed bacteria were several times lower than the levels assessed in serum, bile and the wall of the gallbladder. The infection was eradicated in 20 patients. Seventeen patients were cured (85%).
AuthorsF Vyhnánek, O Lochman, Z Pelák
JournalRozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti (Rozhl Chir) Vol. 75 Issue 11 Pg. 544-8 (Nov 1996) ISSN: 0035-9351 [Print] Czech Republic
Vernacular TitleCefoperazon v lécbĕ infekcí zlucníku, zlucových cest a jater u chirurgických nemocných.
PMID9072836 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Cephalosporins
  • Cefoperazone
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Cefoperazone (therapeutic use)
  • Cephalosporins (therapeutic use)
  • Cholangitis (drug therapy, surgery)
  • Cholecystitis (drug therapy, surgery)
  • Endoscopy
  • Female
  • Humans
  • Liver Abscess (drug therapy, surgery)
  • Male
  • Middle Aged
  • Postoperative Care

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: